Skip to main content
Top
Published in: Journal of Inflammation 1/2014

Open Access 01-12-2014 | Research

Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study

Authors: Nir Erdinest, Haim Ovadia, Ran Kormas, Abraham Solomon

Published in: Journal of Inflammation | Issue 1/2014

Login to get access

Abstract

Background

This study evaluated the anti-inflammatory effects of Resolvin-D1 (RV-D1) and its mechanism of action in human corneal epithelial (HCE) cells.

Methods

HCE cells were incubated with different concentrations of RV-D1 for different time periods. Oleic acid (OA) and Dexamethasone (DM) served as negative and positive controls, respectively. Cells were stimulated with polyriboinosinic:polyribocytidylic acids (poly I:C). The protein contents and mRNA expression levels of Tumor necrosis factor-α (TNF-α), Interleukin (IL)-6, IL-1β and IL-8 were evaluated with multiplex fluorescent bead immunoassay (FBI) and real time-PCR, respectively. In addition, the expression of inhibitory factor-κBα (I-κBα) was evaluated with real time-PCR.

Results

The protein level of pro-inflammatory cytokines TNF-α, IL-6, IL-1β and IL-8 significantly increased after stimulation with Poly I:C. RV-D1 treatment at concentration of 1 μM decreased the protein level of TNF-α to 20.76 ± 9.3% (P < 0.05), IL-6 to 43.54 ± 14.16% (P < 0.001), IL-1β to 46.73 ± 15.93% (P > 0.05) and IL-8 to 51.15 ± 13.01% (P < 0.05) compared with cells stimulated with poly I:C alone. Similarly, the mRNA levels of TNF-α, IL-6, IL-1β and IL-8 were significantly reduced after treatment with RV-D1. A highly significant dose response curve was demonstrated for RV-D1 treated HCE cells for TNF-α and IL-1β.
DM treatment decreased the protein content for all of the pro-inflammatory cytokines, similar results were demonstrated at the mRNA level. The anti-inflammatory effects of RV-D1 were similar to those of DM for TNF-α, IL-6 and IL-8.

Conclusions

RV-D1 may serve as a potent anti-inflammatory agent in ocular surface inflammation, as evaluated in cultured HCE cells. The anti-inflammatory effects of RV-D1 were comparable to those of DM, and were mediated through nuclear factor kappa B (NF-κB) signal transduction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dana MR, Hamrah P: Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Adv Exp Med Biol. 2002, 506 (Pt B): 729-738.PubMedCrossRef Dana MR, Hamrah P: Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Adv Exp Med Biol. 2002, 506 (Pt B): 729-738.PubMedCrossRef
2.
go back to reference Thakur A, Willcox MD: Contact lens wear alters the production of certain inflammatory mediators in tears. Exp Eye Res. 2000, 70 (3): 255-259. 10.1006/exer.1999.0767.PubMedCrossRef Thakur A, Willcox MD: Contact lens wear alters the production of certain inflammatory mediators in tears. Exp Eye Res. 2000, 70 (3): 255-259. 10.1006/exer.1999.0767.PubMedCrossRef
3.
go back to reference Lemp MA: Contact lenses and allergy. Curr Opin Allergy Clin Immunol. 2008, 8 (5): 457-460. 10.1097/ACI.0b013e32830e6adc.PubMedCrossRef Lemp MA: Contact lenses and allergy. Curr Opin Allergy Clin Immunol. 2008, 8 (5): 457-460. 10.1097/ACI.0b013e32830e6adc.PubMedCrossRef
4.
go back to reference Cortina MS, Bazan HE: Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care. 2011, 14 (2): 132-137. 10.1097/MCO.0b013e328342bb1a.PubMedPubMedCentralCrossRef Cortina MS, Bazan HE: Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care. 2011, 14 (2): 132-137. 10.1097/MCO.0b013e328342bb1a.PubMedPubMedCentralCrossRef
5.
go back to reference Marsh P, Pflugfelder SC: Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology. 1999, 106 (4): 811-816. 10.1016/S0161-6420(99)90171-9.PubMedCrossRef Marsh P, Pflugfelder SC: Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology. 1999, 106 (4): 811-816. 10.1016/S0161-6420(99)90171-9.PubMedCrossRef
6.
go back to reference Urban RC, Cotlier E: Corticosteroid-induced cataracts. Surv Ophthalmol. 1986, 31 (2): 102-110. 10.1016/0039-6257(86)90077-9.PubMedCrossRef Urban RC, Cotlier E: Corticosteroid-induced cataracts. Surv Ophthalmol. 1986, 31 (2): 102-110. 10.1016/0039-6257(86)90077-9.PubMedCrossRef
7.
go back to reference Kim SJ, Flach AJ, Jampol LM: Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010, 55 (2): 108-133. 10.1016/j.survophthal.2009.07.005.PubMedCrossRef Kim SJ, Flach AJ, Jampol LM: Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010, 55 (2): 108-133. 10.1016/j.survophthal.2009.07.005.PubMedCrossRef
8.
go back to reference Schrell C, Cursiefen C, Kruse F, Jacobi C: Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca. Klin Monbl Augenheilkd. 2012, 229 (5): 548-553.PubMedCrossRef Schrell C, Cursiefen C, Kruse F, Jacobi C: Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca. Klin Monbl Augenheilkd. 2012, 229 (5): 548-553.PubMedCrossRef
10.
go back to reference Kokke KH, Morris JA, Lawrenson JG: Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008, 31 (3): 141-146. 10.1016/j.clae.2007.12.001.PubMedCrossRef Kokke KH, Morris JA, Lawrenson JG: Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008, 31 (3): 141-146. 10.1016/j.clae.2007.12.001.PubMedCrossRef
11.
go back to reference Viau S, Maire MA, Pasquis B, Gregoire S, Acar N, Bron AM, Bretillon L, Creuzot-Garcher CP, Joffre C: Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009, 247 (8): 1039-1050. 10.1007/s00417-009-1080-z.PubMedCrossRef Viau S, Maire MA, Pasquis B, Gregoire S, Acar N, Bron AM, Bretillon L, Creuzot-Garcher CP, Joffre C: Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009, 247 (8): 1039-1050. 10.1007/s00417-009-1080-z.PubMedCrossRef
12.
go back to reference Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR: Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008, 126 (2): 219-225. 10.1001/archophthalmol.2007.61.PubMedCrossRef Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR: Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008, 126 (2): 219-225. 10.1001/archophthalmol.2007.61.PubMedCrossRef
13.
go back to reference Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A: Anti-inflammatory effects of alpha linolenic Acid on human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2012, 53 (8): 4396-4406. 10.1167/iovs.12-9724.PubMedCrossRef Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A: Anti-inflammatory effects of alpha linolenic Acid on human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2012, 53 (8): 4396-4406. 10.1167/iovs.12-9724.PubMedCrossRef
14.
go back to reference Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O’Neill LA, Perretti M, Rossi AG, Wallace JL: Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007, 21 (2): 325-332. 10.1096/fj.06-7227rev.PubMedPubMedCentralCrossRef Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O’Neill LA, Perretti M, Rossi AG, Wallace JL: Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007, 21 (2): 325-332. 10.1096/fj.06-7227rev.PubMedPubMedCentralCrossRef
15.
go back to reference Zhang MJ, Spite M: Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012, 21 (32): 203-227.CrossRef Zhang MJ, Spite M: Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012, 21 (32): 203-227.CrossRef
16.
go back to reference Ariel A, Serhan CN: Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28 (4): 176-83. 10.1016/j.it.2007.02.007.PubMedCrossRef Ariel A, Serhan CN: Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28 (4): 176-83. 10.1016/j.it.2007.02.007.PubMedCrossRef
17.
go back to reference Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002, 196 (8): 1025-37. 10.1084/jem.20020760.PubMedPubMedCentralCrossRef Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002, 196 (8): 1025-37. 10.1084/jem.20020760.PubMedPubMedCentralCrossRef
18.
go back to reference Serhan CN: Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?. Am J Pathol. 2010, 177 (4): 1576-91. 10.2353/ajpath.2010.100322.PubMedPubMedCentralCrossRef Serhan CN: Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?. Am J Pathol. 2010, 177 (4): 1576-91. 10.2353/ajpath.2010.100322.PubMedPubMedCentralCrossRef
19.
go back to reference Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE: Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther. 2010, 26 (5): 431-9. 10.1089/jop.2010.0019.PubMedPubMedCentralCrossRef Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE: Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther. 2010, 26 (5): 431-9. 10.1089/jop.2010.0019.PubMedPubMedCentralCrossRef
20.
go back to reference de Paiva CS, Schwartz CE, Gjorstrup P, Pflugfelder SC: Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea. 2012, 31 (11): 1299-1303. 10.1097/ICO.0b013e31823f789e.PubMedCrossRef de Paiva CS, Schwartz CE, Gjorstrup P, Pflugfelder SC: Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea. 2012, 31 (11): 1299-1303. 10.1097/ICO.0b013e31823f789e.PubMedCrossRef
21.
go back to reference Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC: Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001, 73 (4): 449-59. 10.1006/exer.2001.1054.PubMedCrossRef Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC: Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001, 73 (4): 449-59. 10.1006/exer.2001.1054.PubMedCrossRef
22.
go back to reference Jumblatt MM, Neufeld AH: Beta-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture. Invest Ophthalmol Vis Sci. 1983, 24 (8): 1139-43.PubMed Jumblatt MM, Neufeld AH: Beta-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture. Invest Ophthalmol Vis Sci. 1983, 24 (8): 1139-43.PubMed
23.
go back to reference Pound EM, Kang JX, Leaf A: Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res. 2001, 42 (3): 346-51.PubMed Pound EM, Kang JX, Leaf A: Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res. 2001, 42 (3): 346-51.PubMed
24.
go back to reference De CR, Cybulsky MI, Clinton SK, Gimbrone MA, Libby P: The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994, 14 (11): 1829-36. 10.1161/01.ATV.14.11.1829.CrossRef De CR, Cybulsky MI, Clinton SK, Gimbrone MA, Libby P: The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994, 14 (11): 1829-36. 10.1161/01.ATV.14.11.1829.CrossRef
25.
go back to reference Ueta M, Hamuro J, Kiyono H, Kinoshita S: Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun. 2005, 331 (1): 285-94. 10.1016/j.bbrc.2005.02.196.PubMedCrossRef Ueta M, Hamuro J, Kiyono H, Kinoshita S: Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun. 2005, 331 (1): 285-94. 10.1016/j.bbrc.2005.02.196.PubMedCrossRef
26.
go back to reference Djalilian AR, Nagineni CN, Mahesh SP, Smith JA, Nussenblatt RB, Hooks JJ: Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin. Cornea. 2006, 25 (6): 709-14. 10.1097/01.ico.0000208815.02120.90.PubMedCrossRef Djalilian AR, Nagineni CN, Mahesh SP, Smith JA, Nussenblatt RB, Hooks JJ: Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin. Cornea. 2006, 25 (6): 709-14. 10.1097/01.ico.0000208815.02120.90.PubMedCrossRef
27.
go back to reference Knoch B, Barnett MP, Cooney J, McNabb WC, Barraclough D, Laing W, Roy NC: Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. Biotechnol J. 2010, 5 (11): 1226-40. 10.1002/biot.201000066.PubMedCrossRef Knoch B, Barnett MP, Cooney J, McNabb WC, Barraclough D, Laing W, Roy NC: Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. Biotechnol J. 2010, 5 (11): 1226-40. 10.1002/biot.201000066.PubMedCrossRef
28.
go back to reference Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995, 184 (1): 39-51. 10.1016/0022-1759(95)00072-I.PubMedCrossRef Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995, 184 (1): 39-51. 10.1016/0022-1759(95)00072-I.PubMedCrossRef
29.
go back to reference Vignali DA: Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000, 243 (1–2): 243-55.PubMedCrossRef Vignali DA: Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000, 243 (1–2): 243-55.PubMedCrossRef
30.
go back to reference Gibson UE, Heid CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res. 1996, 6 (10): 995-1001. 10.1101/gr.6.10.995.PubMedCrossRef Gibson UE, Heid CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res. 1996, 6 (10): 995-1001. 10.1101/gr.6.10.995.PubMedCrossRef
32.
go back to reference Donnenfeld E, Pflugfelder SC: Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009, 54 (3): 321-38. 10.1016/j.survophthal.2009.02.002.PubMedCrossRef Donnenfeld E, Pflugfelder SC: Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009, 54 (3): 321-38. 10.1016/j.survophthal.2009.02.002.PubMedCrossRef
33.
go back to reference Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005, 201 (5): 713-22. 10.1084/jem.20042031.PubMedPubMedCentralCrossRef Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005, 201 (5): 713-22. 10.1084/jem.20042031.PubMedPubMedCentralCrossRef
34.
go back to reference Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD: Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol. 2008, 9 (8): 873-9. 10.1038/ni.1627.PubMedPubMedCentralCrossRef Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD: Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol. 2008, 9 (8): 873-9. 10.1038/ni.1627.PubMedPubMedCentralCrossRef
35.
go back to reference Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M: Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun. 2008, 367 (2): 509-15. 10.1016/j.bbrc.2008.01.012.PubMedCrossRef Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M: Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun. 2008, 367 (2): 509-15. 10.1016/j.bbrc.2008.01.012.PubMedCrossRef
36.
go back to reference Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN: Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA. 2005, 102 (21): 7671-6. 10.1073/pnas.0409271102.PubMedPubMedCentralCrossRef Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN: Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA. 2005, 102 (21): 7671-6. 10.1073/pnas.0409271102.PubMedPubMedCentralCrossRef
37.
go back to reference Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R: Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci. 2009, 50 (10): 4743-52. 10.1167/iovs.08-2462.PubMedPubMedCentralCrossRef Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R: Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci. 2009, 50 (10): 4743-52. 10.1167/iovs.08-2462.PubMedPubMedCentralCrossRef
38.
go back to reference Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ, Min S: Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther. 2011, 24 (4): 434-41. 10.1016/j.pupt.2011.04.001.PubMedCrossRef Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ, Min S: Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther. 2011, 24 (4): 434-41. 10.1016/j.pupt.2011.04.001.PubMedCrossRef
39.
go back to reference Hellmann J, Tang Y, Kosuri M, Bhatnagar A, Spite M: Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 2011, 25 (7): 2399-407. 10.1096/fj.10-178657.PubMedPubMedCentralCrossRef Hellmann J, Tang Y, Kosuri M, Bhatnagar A, Spite M: Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 2011, 25 (7): 2399-407. 10.1096/fj.10-178657.PubMedPubMedCentralCrossRef
40.
go back to reference Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB: Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol. 2011, 187 (4): 1957-69. 10.4049/jimmunol.1101305.PubMedCrossRef Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB: Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol. 2011, 187 (4): 1957-69. 10.4049/jimmunol.1101305.PubMedCrossRef
41.
go back to reference Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR: Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med. 2010, 16 (5): 592-7. 10.1038/nm.2123. 1pPubMedPubMedCentralCrossRef Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR: Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med. 2010, 16 (5): 592-7. 10.1038/nm.2123. 1pPubMedPubMedCentralCrossRef
42.
go back to reference Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN: Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA. 2010, 107 (4): 1660-5. 10.1073/pnas.0907342107.PubMedPubMedCentralCrossRef Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN: Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA. 2010, 107 (4): 1660-5. 10.1073/pnas.0907342107.PubMedPubMedCentralCrossRef
43.
go back to reference Tian H, Lu Y, Sherwood AM, Hongqian D, Hong S: Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest Ophthalmol Vis Sci. 2009, 50 (8): 3613-20. 10.1167/iovs.08-3146.PubMedCrossRef Tian H, Lu Y, Sherwood AM, Hongqian D, Hong S: Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest Ophthalmol Vis Sci. 2009, 50 (8): 3613-20. 10.1167/iovs.08-3146.PubMedCrossRef
44.
go back to reference Hodge W, Barnes D, Schachter HM, Pan Y, Lowcock EC, Zhang L, Sampson M, Morrison A, Tran K, Miguelez M, Lewin G: Effects of omega-3 fatty acids on eye health. Evid Rep Technol Assess (Summ ). 2005, 117: 1-6. Hodge W, Barnes D, Schachter HM, Pan Y, Lowcock EC, Zhang L, Sampson M, Morrison A, Tran K, Miguelez M, Lewin G: Effects of omega-3 fatty acids on eye health. Evid Rep Technol Assess (Summ ). 2005, 117: 1-6.
45.
go back to reference Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG: Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA. 2004, 101 (22): 8491-6. 10.1073/pnas.0402531101.PubMedPubMedCentralCrossRef Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG: Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA. 2004, 101 (22): 8491-6. 10.1073/pnas.0402531101.PubMedPubMedCentralCrossRef
46.
go back to reference Zhao Y, Joshi-Barve S, Barve S, Chen LH: Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr. 2004, 23 (1): 71-8. 10.1080/07315724.2004.10719345.PubMedCrossRef Zhao Y, Joshi-Barve S, Barve S, Chen LH: Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr. 2004, 23 (1): 71-8. 10.1080/07315724.2004.10719345.PubMedCrossRef
47.
go back to reference Ohtsuka Y, Okada K, Yamakawa Y, Ikuse T, Baba Y, Inage E, Fujii T, Izumi H, Oshida K, Nagata S, Yamashiro Y, Shimizu T: Omega-3 fatty acids attenuate mucosal inflammation in premature rat pups. J Pediatr Surg. 2011, 46 (3): 489-95. 10.1016/j.jpedsurg.2010.07.032.PubMedCrossRef Ohtsuka Y, Okada K, Yamakawa Y, Ikuse T, Baba Y, Inage E, Fujii T, Izumi H, Oshida K, Nagata S, Yamashiro Y, Shimizu T: Omega-3 fatty acids attenuate mucosal inflammation in premature rat pups. J Pediatr Surg. 2011, 46 (3): 489-95. 10.1016/j.jpedsurg.2010.07.032.PubMedCrossRef
Metadata
Title
Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study
Authors
Nir Erdinest
Haim Ovadia
Ran Kormas
Abraham Solomon
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2014
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-11-6

Other articles of this Issue 1/2014

Journal of Inflammation 1/2014 Go to the issue